NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
232.51
Dollar change
+3.87
Percentage change
1.69
%
IndexRUT P/E28.28 EPS (ttm)8.22 Insider Own6.14% Shs Outstand16.79M Perf Week3.56%
Market Cap3.90B Forward P/E23.17 EPS next Y10.04 Insider Trans-8.13% Shs Float15.76M Perf Month5.13%
Enterprise Value4.47B PEG2.55 EPS next Q3.20 Inst Own119.48% Short Float13.45% Perf Quarter17.27%
Income141.57M P/S2.31 EPS this Y14.60% Inst Trans10.21% Short Ratio9.71 Perf Half Y39.02%
Sales1.69B P/B4.44 EPS next Y7.71% ROA7.24% Short Interest2.12M Perf YTD38.87%
Book/sh52.38 P/C40.73 EPS next 5Y11.10% ROE16.73% 52W High241.64 -3.78% Perf Year69.86%
Cash/sh5.71 P/FCF163.74 EPS past 3/5Y22.40% 16.36% ROIC10.37% 52W Low129.18 79.99% Perf 3Y172.77%
Dividend Est.- EV/EBITDA16.81 Sales past 3/5Y10.29% 5.41% Gross Margin31.31% Volatility2.77% 2.97% Perf 5Y231.54%
Dividend TTM- EV/Sales2.65 EPS Y/Y TTM12.89% Oper. Margin13.11% ATR (14)7.02 Perf 10Y218.38%
Dividend Ex-Date- Quick Ratio1.38 Sales Y/Y TTM14.93% Profit Margin8.38% RSI (14)60.06 Recom1.33
Dividend Gr. 3/5Y- - Current Ratio2.11 EPS Q/Q22.70% SMA203.05% Beta1.31 Target Price243.33
Payout0.00% Debt/Eq0.75 Sales Q/Q9.61% SMA504.65% Rel Volume0.32 Prev Close228.64
Employees6681 LT Debt/Eq0.55 EarningsMay 01 BMO SMA20025.33% Avg Volume218.42K Price232.51
IPOOct 02, 1997 Option/ShortYes / Yes EPS/Sales Surpr.1.53% 1.80% Trades Volume70,187 Change1.69%
Date Action Analyst Rating Change Price Target Change
Feb-21-25Initiated JP Morgan Neutral $225
Jan-24-25Reiterated B. Riley Securities Buy $180 → $221
Sep-30-24Initiated BofA Securities Buy $175
Sep-18-24Initiated Wells Fargo Overweight $170
Jul-27-21Initiated Imperial Capital Outperform $140
Dec-10-20Initiated Oppenheimer Outperform $110
Nov-13-20Initiated Berenberg Buy $103
Aug-24-18Reiterated B. Riley FBR Buy $81 → $92.50
Jun-21-18Downgrade Sidoti Buy → Neutral
Feb-02-18Downgrade Jefferies Buy → Hold
Jul-03-25 08:30AM
Jul-02-25 08:30AM
Jun-30-25 08:30AM
Jun-26-25 03:58AM
Jun-25-25 07:49PM
08:30AM Loading…
Jun-24-25 08:30AM
Jun-18-25 12:32PM
Jun-16-25 11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM
11:40AM Loading…
11:40AM
Jun-09-25 08:30AM
May-29-25 11:40AM
08:30AM
May-21-25 04:46PM
May-20-25 08:30AM
May-15-25 04:01PM
08:30AM
May-12-25 11:40AM
08:30AM
May-07-25 08:40AM
08:30AM
May-05-25 12:00PM
12:00PM
May-02-25 02:35PM
03:23AM Loading…
03:23AM
03:14AM
May-01-25 04:05PM
10:00AM
09:45AM
08:39AM
08:30AM
Apr-29-25 08:30AM
Apr-23-25 11:40AM
Apr-21-25 09:00PM
08:30AM
Apr-15-25 08:30AM
Apr-14-25 04:45AM
Apr-08-25 07:00PM
08:34AM
Apr-04-25 05:13AM
Apr-03-25 11:50AM
Apr-02-25 08:30AM
Apr-01-25 09:00PM
09:04AM
08:30AM
Mar-31-25 11:40AM
10:20AM
Mar-27-25 08:30AM
Mar-21-25 06:06PM
Mar-19-25 08:30AM
Mar-18-25 05:04AM
Mar-17-25 05:04AM
Mar-14-25 11:50AM
Mar-12-25 05:06AM
Mar-10-25 08:30AM
Feb-24-25 08:30AM
Feb-16-25 02:44PM
Feb-05-25 08:30AM
08:03AM
08:01AM
Jan-29-25 08:30AM
Jan-28-25 08:05AM
08:02AM
Jan-27-25 08:02AM
Jan-26-25 08:01AM
Jan-24-25 12:00PM
03:08AM
02:06AM
Jan-23-25 01:05PM
12:44PM
10:30AM
09:40AM
08:46AM
08:37AM
08:30AM
Jan-22-25 08:02AM
07:06AM
Jan-20-25 09:15AM
Jan-16-25 08:30AM
04:04AM
Jan-15-25 08:30AM
Jan-13-25 06:30PM
08:30AM
Jan-10-25 04:01AM
Jan-08-25 08:30AM
Jan-06-25 08:30AM
Dec-10-24 05:10AM
Dec-06-24 03:15AM
Dec-05-24 05:00PM
Dec-04-24 02:06AM
Dec-02-24 06:33AM
Nov-28-24 04:38AM
Nov-27-24 03:09AM
Nov-26-24 04:27AM
OSI Systems, Inc. engages in the design and manufacture of specialized electronic systems, and components for critical applications. It operates through the following segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment includes security inspection systems and related services, and turnkey security screening solutions. The Healthcare segment provides patient monitoring, diagnostic cardiology, and related services. The Optoelectronics and Manufacturing segment refers to electronic components and electronic manufacturing services. The company was founded by Deepak Chopra in May 1987 and is headquartered in Hawthorne, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LUSKIN MEYER/DirectorJun 12 '25Sale237.151,000237,15011,214Jun 13 06:25 PM
LUSKIN MEYER/DirectorJun 12 '25Proposed Sale236.681,000236,680Jun 12 06:30 PM
Ballhaus William Francis JRDirectorMay 21 '25Sale228.88750171,66024,055May 22 05:13 PM
BALLHAUS TRUSTDirectorMay 21 '25Proposed Sale228.88750171,660May 21 04:13 PM
EDRICK ALAN IEVP & CFOMay 13 '25Sale229.0020,0004,580,000284,953May 15 06:00 PM
ALAN I EDRICKOfficerMay 13 '25Proposed Sale229.0020,0004,580,000May 13 04:22 PM
Grindstaff GlennCHIEF HUMAN RESOURCES OFFICERMay 08 '25Sale224.89688154,7248,354May 09 08:25 PM
GLENN GRINDSTAFFOfficerMay 08 '25Proposed Sale224.89688154,724May 08 04:02 PM
Ballhaus William Francis JRDirectorMay 06 '25Sale219.77933205,04524,805May 07 04:10 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANMay 05 '25Sale221.7920,0004,435,800339,478May 07 04:10 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANMay 06 '25Sale220.115,0001,100,5500May 07 04:10 PM
BALLHAUS TRUSTDirectorMay 06 '25Proposed Sale219.78933205,051May 06 04:09 PM
DEEPAK CHOPRA TTEETHE DEEPIKA OfficerMay 06 '25Proposed Sale220.115,0001,100,541May 06 04:04 PM
CHOPRA FAMILY TRUST U/A DTD 12OfficerMay 05 '25Proposed Sale224.8620,0004,497,200May 05 04:56 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANFeb 04 '25Sale198.2620,0003,965,200364,478Feb 05 02:42 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANFeb 03 '25Sale193.5520,0003,871,000384,478Feb 05 02:42 PM
DEEPAK CHOPRAOfficerFeb 04 '25Proposed Sale198.2620,0003,965,210Feb 04 04:36 PM
CHOPRA FAMILY TRUST U/A DTD 12OfficerFeb 03 '25Proposed Sale196.4420,0003,928,800Feb 03 04:18 PM
Morben Paul KeithPRES., OSI ELECTRONICSJan 30 '25Sale199.3615530,90110,077Jan 31 10:55 AM
PAUL MORBENOfficerJan 30 '25Proposed Sale199.3615530,901Jan 30 04:01 PM
CHIZEVER GERALD MDirectorJan 27 '25Sale195.832,701528,9375,000Jan 27 05:28 PM
CHIZEVER GERALD MDirectorJan 27 '25Proposed Sale195.832,701528,940Jan 27 01:31 PM
EDRICK ALAN IEVP & CFODec 13 '24Sale188.007,6461,437,448304,798Dec 13 05:40 PM
EDRICK ALAN IEVP & CFODec 12 '24Sale188.422,354443,541312,444Dec 13 05:40 PM
CHOPRA DEEPAKPRESIDENT AND CEODec 12 '24Sale187.6620,0003,753,200404,323Dec 13 05:31 PM
ALIABADI MANOOCHER MPRES., OPTOELECTRONICS DIVDec 13 '24Sale180.022,509451,67078,094Dec 13 05:29 PM
MANOOCHER MANSOURI-ALIABADIOfficerDec 13 '24Proposed Sale180.022,509451,676Dec 13 04:41 PM
ALAN EDRICKOfficerDec 13 '24Proposed Sale188.007,6461,437,448Dec 13 04:23 PM
DEEPAK CHOPRAOfficerDec 12 '24Proposed Sale187.6620,0003,753,280Dec 12 05:07 PM
HAWKINS JAMES BDirectorDec 10 '24Sale182.622,000365,2406,396Dec 12 04:43 PM
ALAN EDRICKOfficerDec 12 '24Proposed Sale188.422,354443,547Dec 12 04:43 PM
Ballhaus William Francis JRDirectorDec 10 '24Sale181.63675122,60026,516Dec 12 04:42 PM
BALLHAUS TRUSTDirectorDec 10 '24Proposed Sale181.63675122,598Dec 10 04:36 PM
JAMES HAWKINSDirectorDec 10 '24Proposed Sale182.622,000365,249Dec 10 04:05 PM
ALIABADI MANOOCHER MPRES., OPTOELECTRONICS DIVDec 04 '24Sale180.391,728311,71480,603Dec 06 08:09 AM
MANOOCHER MANSOURI-ALIABADIOfficerDec 04 '24Proposed Sale180.391,728311,713Dec 04 05:00 PM
CHOPRA DEEPAKPRESIDENT AND CEONov 12 '24Sale153.8720,0003,077,400424,323Nov 13 06:00 PM
CHOPRA DEEPAKPRESIDENT AND CEONov 11 '24Sale153.4215,0002,301,2500Nov 13 06:00 PM
CHOPRA 2012 IRREVOCABLE TRUSTspouse Nov 11 '24Proposed Sale153.475,000767,326Nov 12 08:49 AM
THE DEEPIKA CHOPRA TRUSTOfficerNov 11 '24Proposed Sale153.3910,0001,533,882Nov 12 08:47 AM
CHIZEVER GERALD MDirectorNov 07 '24Sale148.162,000296,3207,701Nov 12 08:18 AM
CHIZEVER GERALD MDirectorNov 07 '24Proposed Sale148.162,000296,322Nov 07 05:37 PM
CHOPRA DEEPAKPRESIDENT AND CEOSep 16 '24Sale144.9220,0002,898,400459,033Sep 17 05:00 PM
CHOPRA FAMILY TRUST U/A DTD 12OfficerSep 16 '24Proposed Sale145.3940,0005,815,600Sep 16 04:35 PM
Morben Paul KeithPRES., OSI ELECTRONICSSep 13 '24Sale145.041,107160,55910,077Sep 13 09:55 PM
CHIZEVER GERALD MDirectorSep 11 '24Sale138.413,000415,2303,462Sep 13 05:00 PM
PAUL MORBENOfficerSep 13 '24Proposed Sale145.041,107160,562Sep 13 04:08 PM
CHIZEVER GERALD MDirectorSep 11 '24Proposed Sale138.413,000415,224Sep 11 09:10 PM
Last Close
Jul 03 04:00PM ET
0.4530
Dollar change
-0.0165
Percentage change
-3.51
%
HBIO Harvard Bioscience Inc daily Stock Chart
Index- P/E- EPS (ttm)-1.32 Insider Own15.39% Shs Outstand44.21M Perf Week-11.51%
Market Cap20.03M Forward P/E7.55 EPS next Y0.06 Insider Trans0.00% Shs Float37.41M Perf Month7.58%
Enterprise Value59.09M PEG- EPS next Q-0.03 Inst Own58.50% Short Float7.57% Perf Quarter-22.99%
Income-58.05M P/S0.22 EPS this Y16.67% Inst Trans-19.33% Short Ratio0.23 Perf Half Y-77.57%
Sales91.40M P/B1.35 EPS next Y71.43% ROA-54.52% Short Interest2.83M Perf YTD-78.53%
Book/sh0.34 P/C3.61 EPS next 5Y- ROE-138.80% 52W High3.60 -87.42% Perf Year-83.71%
Cash/sh0.13 P/FCF52.71 EPS past 3/5Y-242.36% -18.10% ROIC-263.09% 52W Low0.28 61.04% Perf 3Y-87.62%
Dividend Est.- EV/EBITDA27.87 Sales past 3/5Y-7.49% -4.12% Gross Margin51.53% Volatility10.66% 14.17% Perf 5Y-84.22%
Dividend TTM- EV/Sales0.65 EPS Y/Y TTM-549.88% Oper. Margin-5.19% ATR (14)0.07 Perf 10Y-92.08%
Dividend Ex-Date- Quick Ratio0.40 Sales Y/Y TTM-14.41% Profit Margin-63.52% RSI (14)48.00 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio0.81 EPS Q/Q-955.08% SMA20-8.78% Beta1.54 Target Price3.00
Payout- Debt/Eq3.01 Sales Q/Q-11.17% SMA508.34% Rel Volume0.05 Prev Close0.47
Employees355 LT Debt/Eq0.49 EarningsMay 12 BMO SMA200-67.80% Avg Volume12.10M Price0.45
IPODec 07, 2000 Option/ShortYes / Yes EPS/Sales Surpr.75.00% 13.41% Trades Volume628,079 Change-3.51%
Date Action Analyst Rating Change Price Target Change
Apr-09-25Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-10-23Upgrade The Benchmark Company Speculative Buy → Buy $3 → $4
Jan-07-21Upgrade The Benchmark Company Speculative Buy → Buy
Dec-09-20Initiated Northland Capital Outperform $6
Nov-10-20Initiated KeyBanc Capital Markets Overweight $6
Jul-08-19Downgrade Janney Buy → Neutral $2
Jan-24-18Reiterated Janney Buy $5 → $8
Jan-23-18Reiterated The Benchmark Company Buy $6 → $10
Nov-17-16Initiated Singular Research Buy $5.50
Jul-28-15Initiated The Benchmark Company Buy $8
Jun-02-25 04:57PM
May-14-25 09:14AM
May-13-25 03:03AM
May-12-25 11:28PM
07:13AM
07:00AM Loading…
07:00AM
May-09-25 09:52AM
May-05-25 04:45PM
Apr-10-25 04:45PM
Mar-13-25 01:18AM
Mar-12-25 04:00PM
07:21AM
Feb-24-25 04:45PM
11:00AM
Jan-21-25 09:00AM
05:52PM Loading…
Jan-13-25 05:52PM
Nov-08-24 02:08AM
Nov-07-24 07:12AM
07:00AM
Nov-06-24 07:50AM
Oct-29-24 05:00PM
Oct-09-24 05:43PM
Oct-03-24 08:00AM
Sep-18-24 07:30AM
Sep-17-24 08:00AM
Sep-05-24 04:05PM
Aug-08-24 08:37AM
08:30AM
Aug-02-24 08:00AM
Jun-06-24 04:05PM
04:05PM Loading…
May-23-24 04:05PM
May-16-24 04:05PM
May-08-24 10:14AM
03:03AM
May-07-24 11:56AM
08:41AM
08:15AM
07:13AM
07:00AM
Apr-29-24 08:45AM
Apr-09-24 09:00AM
Mar-12-24 10:30AM
Mar-11-24 08:00AM
Mar-08-24 10:48AM
Mar-07-24 10:51PM
01:56PM
12:53PM
07:32AM
07:00AM
Mar-06-24 08:30AM
Feb-27-24 05:10PM
Nov-20-23 04:40PM
Nov-09-23 04:30PM
02:28PM
Nov-07-23 09:58PM
08:00AM
07:28AM
07:00AM
Nov-06-23 04:30PM
Oct-30-23 09:00AM
Sep-18-23 08:57AM
Aug-15-23 10:20AM
Aug-08-23 09:43PM
09:15AM
08:05AM
07:18AM
Aug-03-23 06:30PM
Jul-27-23 06:36PM
Jun-22-23 07:55AM
Jun-21-23 08:50AM
Jun-20-23 08:01AM
Jun-13-23 12:21PM
May-25-23 08:50AM
May-24-23 08:26AM
May-23-23 10:17AM
May-09-23 09:40AM
08:50AM
07:15AM
May-02-23 05:01PM
08:35AM
Apr-27-23 06:14PM
Apr-26-23 12:02AM
Apr-25-23 08:41AM
08:01AM
Apr-18-23 05:10PM
Apr-17-23 04:45PM
Apr-11-23 08:28AM
Mar-28-23 06:14AM
Mar-20-23 02:00PM
Mar-16-23 05:14PM
09:25AM
Mar-13-23 02:49AM
Mar-09-23 10:59PM
07:00AM
Mar-06-23 05:09AM
Feb-28-23 04:10PM
Jan-04-23 10:43AM
Dec-12-22 08:30AM
Dec-05-22 05:09AM
Nov-08-22 06:05PM
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.